Jim Cramer says science and technology are responsible for this market strength and we might be seeing the end of the healthcare recession.

Jim Cramer says stocks are oversold, and insiders are buying -- that should give investors hope.

Several Dexcom analysts raised their share-price targets for the diabetes-treatment company after its fourth-quarter earnings beat Wall Street's estimates.

From strong balance sheets to a strong economy, buyers have lots of good reasons to swoop in for the bargains, Jim Cramer says.

The billionaire CEO of Tesla, Elon Musk, strongly supports limiting the rights protecting certain original works.

Alphabet stock has an interesting setup before the tech giant splits the shares. Here's the trade to know.

The software giant hasn't said it will protect user data in wake of Supreme Court ruling overturning Roe.